Cargando…

Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report

Rheumatoid arthritis (RA) is an autoimmune disease mediated by inflammatory processes mainly at the joints. Recently, awareness of Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder (T-LPD) has been heightened for its association with methotraxate usage in RA patients. In the co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokuhira, Michihide, Hanzawa, Kyoko, Watanabe, Reiko, Sekiguchi, Yasunobu, Nemoto, Tomoe, Toyozumi, Yasuo, Tamaru, Jun-ichi, Itoyama, Shinji, Suzuki, Katsuya, Kameda, Hideto, Mori, Shigehisa, Kizaki, Masahiro
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709901/ https://www.ncbi.nlm.nih.gov/pubmed/19566938 http://dx.doi.org/10.1186/1756-8722-2-27

Ejemplares similares

Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders
por: Tokuhira, Michihide, et al.
Publicado: (2019)

The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders
por: Tokuhira, Michihide, et al.
Publicado: (2020)

TM-233, a novel analog of 1′-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities
por: Sagawa, Morihiko, et al.
Publicado: (2015)

Rapid deterioration of intravascular large B-cell lymphoma with mass formation in the trigeminal nerve and multiple organ infiltration: An autopsy case report
por: Tanaka, Yuka, et al.
Publicado: (2021)

Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment
por: Saito, Shuntaro, et al.
Publicado: (2018)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma
por: Higashi, Morihiro, et al.
Publicado: (2022)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndrome.
por: White, A. C., et al.
Publicado: (1989)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
por: Ban, Yumiko, et al.
Publicado: (2020)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020)

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
por: Sankararaman, Senthilkumar, et al.
Publicado: (2014)

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
por: Tse, Eric, et al.
Publicado: (2015)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
por: Latour, Sylvain, et al.
Publicado: (2018)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
por: Crombie, Jennifer L., et al.
Publicado: (2019)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
por: Kwun, Yoojin, et al.
Publicado: (2014)

Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
por: Yachie, Akihiro
Publicado: (2018)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
por: Shahid, Sanam, et al.
Publicado: (2021)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
por: Biggi, Alison Felipe Bordini, et al.
Publicado: (2022)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas
por: Tanaka, Yuka, et al.
Publicado: (2020)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas
por: Ando, Midori, et al.
Publicado: (2013)

An Adult Case of Severe Chronic Active Epstein-Barr Virus Infection with T-Cell Lymphoproliferative Disorder
por: Mun, Se-Kwon, et al.
Publicado: (2012)

A Case of Severe Chronic Active Epstein-Barr Virus Infection with T-cell lymphoproliferative Disorder
por: Cho, Hyun Seok, et al.
Publicado: (2004)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
por: Hyun, Hyesun, et al.
Publicado: (2019)

Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
por: Salmona, Maud, et al.
Publicado: (2020)

Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

Epstein-Barr virus induced post-transplant lymphoproliferative disorder presenting with unilateral retinal involvement
por: Adam, Mainguy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_atgc9fq5ictq6ouq7s3a2sto11